Age

Any age

Sex

MALE

Healthy volunteers

Not accepted

Male, aged 18 years Prostate cancer present (Gleason ≥ 7) and/or
PSA ≥ 15 and/or
Clinical or radiological Stage T3
Subject will be undergoing a pelvic lymph node dissection as part of the prostate cancer treatment.
Subject is willing to sign and date the study Informed Consent form
Signed, written informed consent

Patients who cannot lie still for at least 30 minutes or comply with imaging
Subject has medical conditions that would limit study participation (per physician discretion)
Subject has hemochromatosis and liver disease
Subject has known allergy against Fe-products or dextranes
Subject is enrolled in one or more concurrent studies that would confound the study results of this study as determined by the study investigators
Previous treatment for prostate cancer (surgery, radiotherapy, chemotherapy, hormone androgen deprivation therapy)
Proven bony metastatic disease, visceral metastases or lymph node metastases above the level of the aortic bifurcation
Patients who will not get prostatectomy or pelvic lymph node dissection for any reason
Patient has absolute contra-indications to undergoing MRI scanning

Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRI